New drug shrinks tumours in six advanced and hard-to-treat cancers
Results from a global clinical trial show that using a brand-new drug – currently called GRWD5769 – with an existing type of immunotherapy called cemiplimab can shrink tumours or keep them stable in people with six different advanced and hard-to-treat cancers.
Read New drug shrinks tumours in six advanced and hard-to-treat cancers Article